APA-viite

Tanaka, R., Khatua, S., Zaky, W., Penas-Prado, M., Weathers, S., & Subbiah, V. (2016). EPT-17 PHASE I STUDY OF BRAF INHIBITOR (VEMURAFENIB) IN COMBINATION WITH THE MTOR INHIBITOR (EVEROLIMUS) IN BRAF(V600E) POSITIVE CHILDHOOD AND AYA BRAIN TUMORS. Neuro Oncol.

Chicago-tyylinen lähdeviittaus

Tanaka, Ryuma, Soumen Khatua, Wafik Zaky, Marta Penas-Prado, Shiao-Pei Weathers, ja Vivek Subbiah. "EPT-17 PHASE I STUDY OF BRAF INHIBITOR (VEMURAFENIB) IN COMBINATION WITH THE MTOR INHIBITOR (EVEROLIMUS) IN BRAF(V600E) POSITIVE CHILDHOOD AND AYA BRAIN TUMORS." Neuro Oncol 2016.

MLA-viite

Tanaka, Ryuma, et al. "EPT-17 PHASE I STUDY OF BRAF INHIBITOR (VEMURAFENIB) IN COMBINATION WITH THE MTOR INHIBITOR (EVEROLIMUS) IN BRAF(V600E) POSITIVE CHILDHOOD AND AYA BRAIN TUMORS." Neuro Oncol 2016.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.